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1. Biological systems and computational tools in systems biology
A biological system is defined as the network of biological entities with a specific 
function. Although the study of the genome and its expression process remains 
important, in recent years, researchers have focused on studying the structure and 
dynamics of an entire biological system. The operation of a system determines the 
interactions of its individual elements. Understanding the function and interactions 
of a system is accomplished by comprehension of four basic attributes:  
(1) structures of the system, including the gene interactions and biochemical 
pathways, as well as the control mechanisms of the above procedures, (2) system 
dynamics, containing patterns of the system behavior over time, and the iden-
tification of the main mechanisms that control specific behaviors under various 
conditions, (3) the control method, including configuration of cellular mechanisms 
in order to reduce dysfunctions, (4) the design method, including techniques for 
designing and modifying biological systems to reduce errors. The definition of 
systems biology has not yet been clarified; many different definitions are depending 
on the researcher. In general, systems biology is an interdisciplinary field of biology 
that involves the computational and mathematical modeling of complex biological 
systems. The purpose of this field is to understand the complex interactions and 
functions at the organism, tissue or cell level with direct application in biomedical 
research. Therefore, systems biology comprises an approach that diverges from 
heretofore reductive biological research.
Systems biology examines the interactions between several components rather 
than the individual features of the molecules, in order to understand the pheno-
type resulting from the components of the system. To this end, computational 
approaches are employed in systems biology to create possible in silico models that 
can also be verified experimentally in vivo or in vitro, thus allowing the analysis of 
a large number of data [1–5]. In the study of biological systems, various computa-
tional tools are used including techniques for sequence alignment and for recording 
molecular dynamics, molecular interactions and discovering or predicting the 
molecular structure [6].
The computational techniques are divided into two categories; those guided by 
data and those guided by hypothesis. Network modeling is based on data to provide 
information on the interactions of numerous molecular components. On the other 
hand, dynamic modeling is based on a hypothesis in order to characterize the quan-
titative relations and interactions between the molecular components (Figure 1). 
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This category of computational techniques includes strategies that involve smaller 
biological systems with fewer molecular components [7].
In the context of the computational models’ employment in systems biology, 
there is a correlation between the design of a biological model and the development 
of a computer program. Thus, the researcher can visualize the internal processes 
and flows of system reactions, as well as to study the changes that occur depending 
on the conditions of the system [8].
In a biological network in systems biology, the molecular components are 
considered as “nodes”, while their interactions as “edges”. Molecular components 
include genes, proteins, metabolites, drugs, and can also be diseases and phe-
notypes [9]. On the other hand, the dynamical modeling of a biological system 
involves the representation of known molecular paths in a mathematical form. 
Mathematical equations are intended to describe biological processes based on the 
physicochemical properties that determine the rate of reaction and the affinity of 
the interaction. In order to achieve the most efficient performance of a dynamic 
model, the initial concentrations of cellular components must be given, and their 
connectivity is then established. In this way, through dynamic modeling, the 
concentrations of the components can be calculated at subsequent times and can 
be compared with those that occur in experimental time [5]. A dynamic model can 
be definitive when the initial data and parameters are determined and lead to a 
particular path or can be stochastic when it is able to proceed to different conditions 
with different probabilities according to its primary data [10].
Various tools have been developed for analyzing and modeling biological systems. 
An indicative example is the biological tool COPASI, which is suitable for mathemati-
cal simulation and analysis of the dynamics of biochemical processes [11].  
Figure 1. 
Hypothesis-driven research in systems biology [2].
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BioModel Analyzer (BMA) is a graphical tool for the structure and analysis of 
biological systems. It aims to combine the simple analysis offered by formal-
verification tools to the biologists’ expectations of examining systems spatially 
and temporally and studying the modifications of system interactions according to 
several conditions [12].
BioDiVinE is a tool for parallel study and analysis of biological systems. The tool 
analyzes the model based on its chemical reactions, through the following main 
features: (a) the specificity of models according to their chemical equations through 
the user interface, (b) the representation of models based on the various ordinary 
differential equations (ODEs), (c) adjustment of the initial kinetic parameters 
and conditions, (d) regulation of the discrete abstraction parameters, (e) graphic 
simulation of model’s discrete stages and (f) model controlling [13].
Another example is BoolNet, a computational tool which studies the biological 
Boolean networks (BNs) that describe the gene regulation where the genes exhibit 
dual “on/off” behavior, i.e., whether they are expressed or not. The tool can analyze 
new functions for attractor search, robustness and binarization for three categories 
of BNs: (i) synchronous BNs, consisting of a set of genes (variables) and a set of 
transition functions, (ii) asynchronous BNs, where a single transition function is 
selected, and the corresponding variable is updated, and (iii) probabilistic BNs, that 
allow the specification of various transition functions per variable [14].
2. Applications of systems biology
While traditional reductionist methods provide an invaluable insight into the 
molecular mechanisms of a disease, a systems-level approach has been widely used 
in recent years based on the integration of large-scale data emerging from omics 
technologies. The acquired high-dimensional data produced by genomic, tran-
scriptomic, proteomic, lipidomic and metabolomic technologies can be processed 
and analyzed by employing novel techniques in data analysis and data mining, 
bioinformatics and machine learning approaches. The ultimate goal is the design of 
a refined computational model that can reflect on the dynamic perturbations of the 
system in a predictive mode.
Systems biology approaches have been implemented in the study of many 
diseases, such as cancer and neurodegenerative diseases. Carcinogenesis, tumor 
progression, and metastasis have long been a challenging field of research, since 
high complexity interaction networks govern them at a genetic, epigenetic, cel-
lular, tissue and environmental level [15]. The wide availability of high-throughput 
genomic, epigenomic and transcriptomic data on different types of cancer in large 
repositories, such as “The Cancer Genome Atlas (TCGA),” has empowered research 
in the context of cancer systems biology. The use of such data in parallel with com-
putational models has been employed in a number of successful stories, identifying 
new key regulators, establishing predictive biomarkers and designing optimized or 
novel therapeutic strategies against cancer [16–19].
Another application of systems biology includes the computational analysis on 
extensive experimental data in the field of pharmacology, namely systems pharma-
cology. Systems pharmacology is focused on the study of drugs, identifying new 
drug targets, repurposing of existing drugs and analyzing the properties and effects 
of known drugs in a systems-level. Addressing the complexity of the cellular net-
works and the mode of action of a drug can lead to a better understanding of side 
effects and adverse events of a drug and the identification of off-targets, improving 
the safety and effectiveness of disease treatment [20]. In the past decade, systems-
based applications have proved to gain better insights into drug-drug interactions, 
Systems Biology
4
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Author details
Eleni Papakonstantinou, Katerina Pierouli, Elias Eliopoulos  
and Dimitrios Vlachakis*
Department of Biotechnology, Genetics and Computational Biology Group, 
Laboratory of Genetics, Agricultural University of Athens, Athens, Greece
*Address all correspondence to: dimvl@aua.gr
drug-target networks, drug-target interactions, and drug side-effects, leading to 
novel drug discovery [21–23].
Finally, in the field of virology, a systems-level approach is required to address 
the extremely complex viral and host processes that follow upon viral infection. 
Systems virology encompasses the study of virus-host interaction networks through 
the process and analysis of high-throughput data, such as next-generation sequenc-
ing, mass spectrometry, microarray technologies, and protein-protein interactions, 
aiming towards the generation of a representative dynamic model of virus-host 
interactions [24]. Such methods may reveal key network components that can be 
used as potential targets during viral infection and replication and lead to novel 
preventive or therapeutic antiviral strategies [25].
Summarizing, systems biology is a field that aims to analyze and model the 
molecular pathways and interactions of a broader set of several molecular compo-
nents. The study of a system can be achieved by computational tools that enable 
scientists to visualize and record the progress of functions in a system over time. 
The ultimate ambition is the prediction of potential changes and interactions 
according to the dynamic conditions, making it possible to lead to the development 
of more effective therapies and handling several diseases.
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